Shopping Cart 0
Cart Subtotal
USD 0

Yeda Research and Development Company Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Yeda Research and Development Company Ltd (Yeda), a subsidiary of Weizmann Institute of Science, is a technology transfer company that provides research and science education. The company identifies and assesses research projects with commercial potential, protects the intellectual property of the institute and its scientists, licenses the institute's inventions and technologies to industry, and channels funding from industry to research projects. It caters to biotechnology, pharmaceuticals and diagnostics, bioinformatics, proteomics, agriculture and plant genetics, biomatics and system biology, medical devices, renewable energy, bio-fuels, cleantech and environmental sciences, bio-fuels, chemistry and nanotechnology, physics and electro-optics, and mathematics and computer science industries. Yeda is headquartered in Rehovot, Israel.

Yeda Research and Development Company Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Yeda Research and Development Company Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Galmed Pharma Enters into Research Agreement with Yeda Research and Development 11

XL-protein Enters into Collaboration Agreement with Yeda Research 12

Immune Pharma Enters Into Co-Development Agreement With Yeda Research 13

Licensing Agreements 14

Stem Cell Medicine Enters into Licensing Agreement with Ramot at Tel Aviv University and Yeda Research and Development 14

TxCell Exercises Option for Licensing Agreement with Yeda Research and Development 15

Tikcro Technologies Amends Research and Licensing Agreement with Yeda Research and Development 16

Soligenix Enters into Licensing Agreement with New York University and Yeda Research and Development 17

XTL Biopharma Amends Licensing Agreement with Yeda Research for hCDR1 18

miCure Therapeutics Enters into Licensing Agreement with Yeda Research 20

PsychoGenics Enters into Licensing Agreement with Yeda Research and Development 21

Yeda Research and Development Company Ltd-Key Competitors 22

Yeda Research and Development Company Ltd-Key Employees 23

Yeda Research and Development Company Ltd-Locations And Subsidiaries 24

Head Office 24

Recent Developments 25

Product News 25

Jan 23, 2017: RondinX Expands its Microbiome Computational Platform for Drug Development with a Unified Reference Range of Bacterial Dynamics Based on Database of 1,400 Healthy Individuals 25

Appendix 26

Methodology 26

About GlobalData 26

Contact Us 26

Disclaimer 26


List Of Figure

List of Figures

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Yeda Research and Development Company Ltd, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Key Facts 2

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Yeda Research and Development Company Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Yeda Research and Development Company Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Galmed Pharma Enters into Research Agreement with Yeda Research and Development 11

XL-protein Enters into Collaboration Agreement with Yeda Research 12

Immune Pharma Enters Into Co-Development Agreement With Yeda Research 13

Stem Cell Medicine Enters into Licensing Agreement with Ramot at Tel Aviv University and Yeda Research and Development 14

TxCell Exercises Option for Licensing Agreement with Yeda Research and Development 15

Tikcro Technologies Amends Research and Licensing Agreement with Yeda Research and Development 16

Soligenix Enters into Licensing Agreement with New York University and Yeda Research and Development 17

XTL Biopharma Amends Licensing Agreement with Yeda Research for hCDR1 18

miCure Therapeutics Enters into Licensing Agreement with Yeda Research 20

PsychoGenics Enters into Licensing Agreement with Yeda Research and Development 21

Yeda Research and Development Company Ltd, Key Competitors 22

Yeda Research and Development Company Ltd, Key Employees 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Yeda Research and Development Company Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.